Atlas Trials

Study Evaluating the Efficacy and Safety of Etanercept

Clinical trial NCT00546533 · COMPLETED

Trial details

NCT number
NCT00546533
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2003-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.